Cytokine Induced Killer Cells as Post-Transplant Immunotherapy Following Allogeneic Hematopoietic Cell Transplantation

NCT00185757 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma
Blood and Marrow Transplant (BMT)

Interventions

DRUG: Cytokine Induced Killer Cells

Sponsor

Robert Negrin

Collaborators

[object Object]